Abstract
The in vitro activities of CG400549, a novel FabI inhibitor, were compared to those of linezolid and commonly used antimicrobials against recent bacterial isolates. CG400549 had an MIC90 of 0.5 μg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin.
| Original language | English |
|---|---|
| Pages (from-to) | 2591-2593 |
| Number of pages | 3 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 51 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2007 Jul 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Cite this
}
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea. / Jong, Hwa Yum; Chang, Ki Kim; Yong, Dongeun; Lee, Kyungwon; Chong, Yunsop; Cheol, Min Kim; Jeong, Mi Kim; Ro, Seonggu; Joong, Myung Cho.
In: Antimicrobial agents and chemotherapy, Vol. 51, No. 7, 01.07.2007, p. 2591-2593.Research output: Contribution to journal › Article
TY - JOUR
T1 - In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea
AU - Jong, Hwa Yum
AU - Chang, Ki Kim
AU - Yong, Dongeun
AU - Lee, Kyungwon
AU - Chong, Yunsop
AU - Cheol, Min Kim
AU - Jeong, Mi Kim
AU - Ro, Seonggu
AU - Joong, Myung Cho
PY - 2007/7/1
Y1 - 2007/7/1
N2 - The in vitro activities of CG400549, a novel FabI inhibitor, were compared to those of linezolid and commonly used antimicrobials against recent bacterial isolates. CG400549 had an MIC90 of 0.5 μg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin.
AB - The in vitro activities of CG400549, a novel FabI inhibitor, were compared to those of linezolid and commonly used antimicrobials against recent bacterial isolates. CG400549 had an MIC90 of 0.5 μg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin.
UR - http://www.scopus.com/inward/record.url?scp=34447263022&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447263022&partnerID=8YFLogxK
U2 - 10.1128/AAC.01562-06
DO - 10.1128/AAC.01562-06
M3 - Article
C2 - 17420210
AN - SCOPUS:34447263022
VL - 51
SP - 2591
EP - 2593
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
SN - 0066-4804
IS - 7
ER -